Company Filing History:
Years Active: 2022
Title: Caitríona Grönberg: Innovator in Antibody Development
Introduction
Caitríona Grönberg is a notable inventor based in Torna-Hällestad, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for medical treatments.
Latest Patents
Caitríona Grönberg holds a patent for an Anti-IL1RAP antibody. This invention relates to an antibody or antigen-binding fragment that specifically binds to interleukin-1 receptor accessory protein (IL1RAP). The patent also encompasses a polynucleotide encoding the antibody, a vector containing the polynucleotide, and a recombinant host cell that includes the polynucleotide or vector. Additionally, it describes methods for producing the antibody and its applications in medicine, particularly for diseases associated with IL-1 signaling.
Career Highlights
Caitríona Grönberg is associated with Cantargia AB, a company dedicated to developing innovative cancer therapies. His work has contributed to advancements in the understanding and treatment of diseases linked to IL1RAP.
Collaborations
Caitríona collaborates with esteemed colleagues, including David Liberg and Camilla Rydberg Millrud. Their combined expertise enhances the research and development efforts at Cantargia AB.
Conclusion
Caitríona Grönberg's innovative work in antibody development exemplifies the potential of biotechnology in addressing complex medical challenges. His contributions are paving the way for new therapeutic options in the treatment of various diseases.